Research ArticleArticle
Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry
Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, Niels Steen Krogh, Anja Thormann, Ulrik Tarp, Uta Engling Poulsen, Jakob Espesen, Annette Schlemmer, Niels Graudal, Gina Kollerup, Dorte Vendelbo Jensen, Ole Rintek Madsen, Bente Glintborg, Torben Christensen, Hanne Lindegaard, Wolfgang Bøhme, Annette Hansen, Anne Rødgaard Andersen and Merete Lund Hetland
The Journal of Rheumatology December 2014, 41 (12) 2352-2360; DOI: https://doi.org/10.3899/jrheum.131299
Lykke Midtbøll Ørnbjerg
From the DANBIO registry and Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,
Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo,
Norway; Zitelab Aps, Copenhagen; Department of Rheumatology, Aarhus University Hospital, Aarhus; Rheumatism Hospital, University of Southern Denmark, Gråsten; Department of Internal Medicine, Lillebælt Hospital, Vejle; Department of Rheumatology, Aarhus University Hospital, Aalborg; Department of Rheumatology, Copenhagen University Hospital Rigshospitalet; Department of Rheumatology, Copenhagen University Hospital Frederiksberg, Copenhagen; Department of Rheumatology, Helsingør Hospital, Helsingør; Department of Rheumatology/C, Copenhagen University Hospital Gentofte, Hellerup; Department of Internal Medicine, Holbæk Hospital, Holbæk; Department of Rheumatology, Copenhagen University Hospital Slagelse, Slagelse; Department of Rheumatology, Odense University Hospital, Odense; Department of Medicine, Hospital of South West Jutland, Esbjerg; Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Glostrup,
Denmark.
Mikkel Østergaard
Pernille Bøyesen
Niels Steen Krogh
Anja Thormann
Ulrik Tarp
Uta Engling Poulsen
Jakob Espesen
Annette Schlemmer
Niels Graudal
Gina Kollerup
Dorte Vendelbo Jensen
Ole Rintek Madsen
Bente Glintborg
Torben Christensen
Hanne Lindegaard
Wolfgang Bøhme
Annette Hansen
Anne Rødgaard Andersen
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 41, Issue 12
1 Dec 2014
Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry
Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, Niels Steen Krogh, Anja Thormann, Ulrik Tarp, Uta Engling Poulsen, Jakob Espesen, Annette Schlemmer, Niels Graudal, Gina Kollerup, Dorte Vendelbo Jensen, Ole Rintek Madsen, Bente Glintborg, Torben Christensen, Hanne Lindegaard, Wolfgang Bøhme, Annette Hansen, Anne Rødgaard Andersen, Merete Lund Hetland
The Journal of Rheumatology Dec 2014, 41 (12) 2352-2360; DOI: 10.3899/jrheum.131299
Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry
Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, Niels Steen Krogh, Anja Thormann, Ulrik Tarp, Uta Engling Poulsen, Jakob Espesen, Annette Schlemmer, Niels Graudal, Gina Kollerup, Dorte Vendelbo Jensen, Ole Rintek Madsen, Bente Glintborg, Torben Christensen, Hanne Lindegaard, Wolfgang Bøhme, Annette Hansen, Anne Rødgaard Andersen, Merete Lund Hetland
The Journal of Rheumatology Dec 2014, 41 (12) 2352-2360; DOI: 10.3899/jrheum.131299